| Literature DB >> 29374066 |
Ting-Ting Yan1, Lin-Lin Ren1,2, Chao-Qin Shen1, Zhen-Hua Wang1, Ya-Nan Yu1,2, Qian Liang1, Jia-Yin Tang3, Ying-Xuan Chen1, Dan-Feng Sun1,4, Witold Zgodzinski5, Marek Majewski5, Piotr Radwan6, Ilona Kryczek4, Ming Zhong3, Jinxian Chen3, Qiang Liu7, Weiping Zou8, Hao-Yan Chen9, Jie Hong9, Jing-Yuan Fang9.
Abstract
Colorectal cancer includes an invasive stem-like/mesenchymal subtype, but its genetic drivers, functional, and clinical relevance are uncharacterized. Here we report the definition of an altered miRNA signature defining this subtype that includes a major genomic loss of miR-508. Mechanistic investigations showed that this miRNA affected the expression of cadherin CDH1 and the transcription factors ZEB1, SALL4, and BMI1. Loss of miR-508 in colorectal cancer was associated with upregulation of the novel hypoxia-induced long noncoding RNA AK000053. Ectopic expression of miR-508 in colorectal cancer cells blunted epithelial-to-mesenchymal transition (EMT), stemness, migration, and invasive capacity in vitro and in vivo In clinical colorectal cancer specimens, expression of miR-508 negatively correlated with stemness and EMT-associated gene expression and positively correlated with patient survival. Overall, our results showed that miR-508 is a key functional determinant of the stem-like/mesenchymal colorectal cancer subtype and a candidate therapeutic target for its treatment.Significance: These results define a key functional determinant of a stem-like/mesenchymal subtype of colorectal cancers and a candidate therapeutic target for its treatment. Cancer Res; 78(7); 1751-65. ©2018 AACR. ©2018 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29374066 DOI: 10.1158/0008-5472.CAN-17-2101
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701